Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|December 12, 2003
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIBIngrid Glimelius, Daniel Molin, Rose-Marie Amini, et al.
Immunobiology|December 3, 2019
Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphomaPeter Hollander, Beatrice Ginman, Daniel Molin, et al.
Plos One|September 28, 2018
Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphomaPeter Hollander, Rose-Marie Amini, Beatrice Ginman, et al.
American Journal of Hematology|December 23, 2016
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapyIngrid Glimelius, Sandra Eloranta, Sara Ekberg, et al.
British Journal of Haematology|October 3, 2002
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphomaDaniel Molin, Annika Edström, Ingrid Glimelius, et al.
Scandinavian Journal of Immunology|November 21, 2007
Expression of mast cell tryptases in Hodgkin and Reed-Sternberg (HRS) cellsRicardo F S Carvalho, Yilmaz Mahshid, Hans-Erik Claesson, et al.
Scandinavian Journal of Gastroenterology|December 15, 2015
Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomyMohammad Mohammadi, Huan Song, Yang Cao, et al.
Blood Advances|August 16, 2022
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantationSara Ekberg, Karin E Smedby, Alexandra Albertsson-Lindblad, et al.
Experimental Hematology|June 18, 2011
Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell linesIngrid Glimelius, Jenny Rubin, Marie Fischer, et al.
Pageof 12